Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women

NCT00471120 is registered in ClinicalTrials.gov with Dick Domanik as lead sponsor.

NCT NCT00471120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00471120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Lead sponsor
Dick Domanik
Phase
Not applicable
Overall status
Terminated
Start date
November 30, 2006
Completion date
February 29, 2008
Enrollment
20 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, uterine cancer